Interferonbeta1a/Humaninterferonbeta1a

Interferonbeta1a/Humaninterferonbeta1a 구조식 이미지
카스 번호:
145258-61-3
상품명:
Interferonbeta1a/Humaninterferonbeta1a
동의어(영문):
IFN-beta;Interferon β-1a;Unii-xro4566Q4r;interferon beta 1a;Interferon beta-1a CRS;Interferonbeta1a/Humaninterferonbeta1a;Interferon beta1 (human fibroblast protein moiety);Interferon Beta-1A (1.0 mL) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED);Interferon Beta-1A for Bioidentity (200 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED)
CBNumber:
CB01074453
분자식:
포뮬러 무게:
0
MOL 파일:
Mol file

Interferonbeta1a/Humaninterferonbeta1a 속성

저장 조건
-70°C

안전

RTECS 번호 NM9701100
유해 물질 데이터 145258-61-3(Hazardous Substances Data)

Interferonbeta1a/Humaninterferonbeta1a C화학적 특성, 용도, 생산

개요

Launched in the US for relapsing forms of multiple sclerosis (MS), interferon β-1a is the second compound to be marketed for MS next to interferon p-lb (Betaseron). This form of p-interferon is a glycosylated polypeptide of 166 amino acids (sequence identical to human) produced from cultured Chinese hamster ovary cells containing the engineered human gene for interferon β-1a. The difference in structure to interferon β-1b lies in the substitution of a cysteine for a serine and in the fact it is glycosylated. The I b form requires reconstitution and subcutaneous injection every other day, while the l a form is an intramuscular injection once a week. The exact mode of action for the β-interferons has not been delineated, however, it is thought that they reverse a suppressor cell defect and favor the generation of T helper-2 type responses. It is presumed that the immunoregulatory and antiviral actions, in addition to the antagonistic effect they have on γ-interferon (γ-interferon has been shown to exacerbate the symptoms of MS), provide an overall beneficial effect.

용도

Antineoplastic; biological response modifier.

일반 설명

Interferon beta-1a (recombinant), Avonex, is a glycoproteinwith 166 amino acids. It has a molecular mass of approximately22,000 Da.Interferon beta-1a is indicated for the treatment of relapsingforms of MS. Patients treated with interferon beta-1ademonstrate a slower progression to disability and a less noticeablebreakdown of the blood-brain barrier as observed ingadolinium-enhanced magnetic resonance imaging (MRI). Although the exact mechanism of action of interferonbeta-1a in MS has not been elucidated, it is known that thedrug exerts its biological effects by binding to specific receptorson the surface of human cells. This binding initiatesa cascade of intracellular events that lead to the expressionof interferon-induced gene products.
Adverse effects include flulike syndrome at the start oftherapy that decreases in severity as treatment progresses.Interferon beta-1a is a potential abortifacient and an inhibitorof cytochrome P450.The dosage form is a powder for solution that is reconstitutedin sterile water. Excipients are human albumin,sodium chloride, and phosphate buffer.

Interferonbeta1a/Humaninterferonbeta1a 준비 용품 및 원자재

원자재

준비 용품


Interferonbeta1a/Humaninterferonbeta1a 공급 업체

글로벌( 18)공급 업체
공급자 전화 이메일 국가 제품 수 이점
AFINE CHEMICALS LIMITED
+86-0571-85134551
info@afinechem.com China 15395 58
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12338 58
Nanjing Shizhou Biology Technology Co.,Ltd 13675144456
sean.lv@synzest.com China 10787 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
3287908757@qq.com China 9118 58

Copyright 2019 © ChemicalBook. All rights reserved